Kimlin Ashing1, Monica Rosales, Lily Lai, Arti Hurria. 1. Center of Community Alliance for Research and Education (CCARE), Department of Population Sciences, City of Hope National Medical Center, 1500 E Duarte Road, Duarte, CA, 91010-3000, USA, kashing@coh.org.
Abstract
BACKGROUND: The co-occurrence of multiple chronic conditions in cancer patients is common and can have negative impact on cancer and cancer survivorship outcomes. This study aimed to document comorbidity occurrence among African-American and Latina (English language preferred (ELP) and Spanish language preferred (SLP)) breast cancer survivors (BCS). METHODS: Eighty-eight African-American, 95 ELP Latina, and 137 SLP Latina BCS were recruited via case ascertainment from the California Cancer Registry and hospital registries. BCS completed a self-report questionnaire assessing demographic and cancer characteristics, and presence of comorbidities. RESULTS: Overall, 75% of BCS reported at least one comorbidity with arthritis (37%), high blood pressure (37%), psychological difficulties (29%), and diabetes (19%) being most commonly endorsed. SLP Latinas were more likely to report diabetes (29%), psychological difficulties (42%), and >3 comorbidities (p < 0.05). Latina BCS were twice as likely to report osteoporosis and headaches compared to African-Americans; while one in two African-Americans reported hypertension and arthritis. Older age was correlated with arthritis, diabetes, glaucoma, high blood pressure, and osteoporosis. CONCLUSIONS: Our findings suggest that investigating the occurrence of comorbidities across ethnic groups may shed some light in understanding cancer survivorship risk for poor health outcomes and health disparities. Having a better grasp of comorbid conditions may aid in more appropriate early assessment, better follow-up care, surveillance, and management of the cancer and the comorbid condition(s). IMPLICATIONS FOR CANCER SURVIVORS: Integrated control and management of comorbidities among cancer survivors has the potential to improve quality care for the whole person, and increase survival and decrease morbidity.
BACKGROUND: The co-occurrence of multiple chronic conditions in cancerpatients is common and can have negative impact on cancer and cancer survivorship outcomes. This study aimed to document comorbidity occurrence among African-American and Latina (English language preferred (ELP) and Spanish language preferred (SLP)) breast cancer survivors (BCS). METHODS: Eighty-eight African-American, 95 ELP Latina, and 137 SLP Latina BCS were recruited via case ascertainment from the California Cancer Registry and hospital registries. BCS completed a self-report questionnaire assessing demographic and cancer characteristics, and presence of comorbidities. RESULTS: Overall, 75% of BCS reported at least one comorbidity with arthritis (37%), high blood pressure (37%), psychological difficulties (29%), and diabetes (19%) being most commonly endorsed. SLP Latinas were more likely to report diabetes (29%), psychological difficulties (42%), and >3 comorbidities (p < 0.05). Latina BCS were twice as likely to report osteoporosis and headaches compared to African-Americans; while one in two African-Americans reported hypertension and arthritis. Older age was correlated with arthritis, diabetes, glaucoma, high blood pressure, and osteoporosis. CONCLUSIONS: Our findings suggest that investigating the occurrence of comorbidities across ethnic groups may shed some light in understanding cancer survivorship risk for poor health outcomes and health disparities. Having a better grasp of comorbid conditions may aid in more appropriate early assessment, better follow-up care, surveillance, and management of the cancer and the comorbid condition(s). IMPLICATIONS FOR CANCER SURVIVORS: Integrated control and management of comorbidities among cancer survivors has the potential to improve quality care for the whole person, and increase survival and decrease morbidity.
Authors: Helen M Parsons; Elizabeth B Habermann; Steven C Stain; Selwyn M Vickers; Waddah B Al-Refaie Journal: J Am Coll Surg Date: 2012-02-08 Impact factor: 6.113
Authors: W J Louwman; M L G Janssen-Heijnen; S Houterman; A C Voogd; M J C van der Sangen; G A P Nieuwenhuijzen; J W W Coebergh Journal: Eur J Cancer Date: 2005-03 Impact factor: 9.162
Authors: Kimberly S Peairs; Bethany B Barone; Claire F Snyder; Hsin-Chieh Yeh; Kelly B Stein; Rachel L Derr; Frederick L Brancati; Antonio C Wolff Journal: J Clin Oncol Date: 2010-11-29 Impact factor: 44.544
Authors: Nancy K Janz; Mahasin S Mujahid; Sarah T Hawley; Jennifer J Griggs; Amy Alderman; Ann S Hamilton; John Graff; Steven J Katz Journal: J Cancer Surviv Date: 2009-09-16 Impact factor: 4.442
Authors: Marium Husain; Timiya S Nolan; Kevin Foy; Raquel Reinbolt; Cassandra Grenade; Maryam Lustberg Journal: Support Care Cancer Date: 2018-11-20 Impact factor: 3.603
Authors: Cathy Samayoa; Jasmine Santoyo-Olsson; Cristian Escalera; Anita L Stewart; Carmen Ortiz; Leticia Márquez-Magaña; Aday Urias; Nayeli Gonzalez; Silvia A Cervantes; Alma Torres-Nguyen; Lorenia Parada-Ampudia; Anna M Nápoles Journal: Cancer Epidemiol Biomarkers Prev Date: 2020-03 Impact factor: 4.254
Authors: Krista Beth Highland; Alejandra Hurtado-de-Mendoza; Cassandra A Stanton; Chiranjeev Dash; Vanessa B Sheppard Journal: Support Care Cancer Date: 2014-09-21 Impact factor: 3.603